M. Bajo

Effects of cholinergic muscarinic blockade on growth hormone responses to growth hormone-releasing hormone in uraemic patients.

R. Selgas, P. Iglesias, J. Díez, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cultures of human osteoblastic cells from dialysis patients: influence of bone turnover rate on in vitro selection of interleukin-6 and osteoblastic cell makers.

R. Selgas, P. Esbrit, M. Bajo, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Anorexigen (TNF-alpha, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients: their relationship with nutritional parameters.

R. Selgas, M. Bajo, A. Aguilera, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Effects of Recombinant Human Erythropoietin on Functional and Injury Endothelial Markers in Peritoneal Dialysis Patients

R. Selgas, Á. Hernanz, A. Aguilera, 1999, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Cholinergic modulation of growth hormone responses to growth hormone‐releasing hormone in uraemic patients on peritoneal dialysis

R. Selgas, M. Bajo, P. Iglesias, 2000, Clinical endocrinology.

Short-term recombinant human growth hormone therapy does not modify growth hormone, thyrotropin and prolactin responses to thyrotropin-releasing hormone in adult dialysis patients.

R. Selgas, P. Iglesias, J. Díez, 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Effects of erythropoietin on gonadotropin responses to gonadotropin-releasing hormone in uremic patients.

R. Selgas, P. Iglesias, J. Díez, 1997, Nephron.

Long-term effects of recombinant human erythropoietin therapy on growth hormone secretion in uremic patients undergoing peritoneal dialysis.

R. Selgas, P. Iglesias, J. Díez, 1999, Metabolism: clinical and experimental.

Are low concentrations of serum triiodothyronine a good marker for long-term mortality in hemodialysis patients?

R. Selgas, A. Molina, P. Iglesias, 2010, Clinical nephrology.

Effects of short-term recombinant human growth hormone therapy on plasma leptin concentrations in dialysis patients.

R. Selgas, P. Iglesias, J. Díez, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.